Stay updated on MEDI8897 for RSV Prevention in High-risk Kids Clinical Trial
Sign up to get notified when there's something new on the MEDI8897 for RSV Prevention in High-risk Kids Clinical Trial page.

Latest updates to the MEDI8897 for RSV Prevention in High-risk Kids Clinical Trial page
- Check4 days agoChange DetectedThe location string is updated to México with the same 06720 code, and the revision is bumped to v3.0.2. The Back to Top link was removed.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as updated drug information for Nirsevimab. The previous drug information for Palivizumab has been removed.SummaryDifference10%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to MEDI8897 for RSV Prevention in High-risk Kids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI8897 for RSV Prevention in High-risk Kids Clinical Trial page.